Takeda Pharmaceutical Co. (TAK)
(Delayed Data from NYSE)
$14.82 USD
-0.03 (-0.20%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $14.82 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
A Value D Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/24/24 |
---|---|
Current Quarter | 0.42 |
EPS Last Quarter | 0.56 |
Last EPS Surprise | 51.35% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.58 |
Next Year | 1.59 |
EPS (TTM) | 1.57 |
P/E (F1) | 9.42 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 29.83B | 29.39B |
# of Estimates | NA | NA | 1 | 2 |
High Estimate | NA | NA | 29.83B | 30.10B |
Low Estimate | NA | NA | 29.83B | 28.68B |
Year ago Sales | 6.94B | 7.52B | 27.57B | 29.83B |
Year over Year Growth Est. | NA | NA | 8.19% | -1.47% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.42 | NA | 1.58 | 1.59 |
# of Estimates | 1 | NA | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.42 | NA | 1.63 | 1.77 |
Low Estimate | 0.42 | NA | 1.47 | 1.36 |
Year ago EPS | 0.50 | 0.51 | 1.67 | 1.58 |
Year over Year Growth Est. | -16.00% | NA | -5.39% | 0.84% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 1 | 0 |
Up Last 30 Days | 0 | NA | 1 | 0 |
Up Last 60 Days | 0 | NA | 3 | 1 |
Down Last 7 Days | 0 | NA | 0 | 0 |
Down Last 30 Days | 0 | NA | 0 | 0 |
Down Last 60 Days | 0 | NA | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | 0.42 | NA | 1.58 | 1.59 |
7 Days Ago | NA | NA | 1.52 | 1.59 |
30 Days Ago | NA | NA | 1.52 | 1.59 |
60 Days Ago | NA | NA | 1.38 | 1.56 |
90 Days Ago | NA | NA | 1.37 | 1.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.42 | NA | 1.63 | 1.59 |
Zacks Consensus Estimate | 0.42 | NA | 1.58 | 1.59 |
Earnings ESP | 0.00% | NA | 3.38% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.56 | 0.00 | 0.51 | 0.50 | NA |
Estimate | 0.37 | NA | NA | NA | NA |
Difference | 0.19 | NA | NA | NA | 0.19 |
Surprise | 51.35% | NA | NA | NA | 51.35% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more